首页> 外文期刊>Ophthalmic Surgery and Lasers >The 'deroofing' of Schlemm's canal in patients with open-angle glaucoma through placement of a collagen drainage device.
【24h】

The 'deroofing' of Schlemm's canal in patients with open-angle glaucoma through placement of a collagen drainage device.

机译:通过放置胶原蛋白引流装置,对开角型青光眼患者的施莱姆管进行“脱水”。

获取原文
获取原文并翻译 | 示例
       

摘要

BACKGROUND AND OBJECTIVES: A preliminary study was conducted to examine a new surgical approach for the management of patients with open-angle glaucoma in which Schlemm's canal is opened to restore drainage in a nonpenetrating fashion. The authors compared the results of the surgical procedure including the new glaucoma drainage device with the results of standard trabeculectomy. PATIENTS AND METHODS: The authors performed a new type of surgical procedure on 58 consecutive patients with open-angle glaucoma. The procedure entails "deroofing" Schlemm's canal to facilitate the drainage of aqueous without penetrating the eye. This is done by exposing the canal after a partial-thickness sclerectomy and keratectomy along a 5-mm arc. After the canal was deroofed, a new type of collagen glaucoma drainage device was placed in the surgical site to maintain drainage postoperatively. Patient data, including intraocular pressure (IOP), complications, and the number of medications required to maintain adequate pressures, were analyzed for 1 year postoperatively. RESULTS: Within 1 to 2 months postoperatively, 80.9% of the patients achieved an IOP lower than 21 mm Hg. This improved to 88.9% at 3 to 6 months postoperatively and 87.5% at 6 to 12 months postoperatively. The only major complications were microperforations (8.6%) related to surgical technique and a few cases of high IOP that required repeat operations (10.3%). CONCLUSIONS: The nonpenetrating technique for deroofing the canal effectively allows the drainage of aqueous to acceptable levels (in the range of 15 to 17 mm Hg) without the complications associated with penetrating trabeculectomy. Complications are rare, and the collagen drainage device appears to be effective for allowing the drainage site to remain patent after its dissolution.
机译:背景与目的:进行了一项初步研究,以检查一种新的手术方法来处理开角型青光眼患者,其中张开施勒姆氏管以非穿透性方式恢复引流。作者将包括新的青光眼引流装置在内的外科手术结果与标准小梁切除术的结果进行了比较。患者和方法:作者对58例连续性开角型青光眼患者进行了新型手术。该过程需要“施乐”(Schlemm)根管“萎缩”,以促进水的引流而不会穿透眼睛。这是通过在部分厚度的巩膜切除术和角膜切除术后沿5毫米弧线暴露运河来完成的。根管切开后,在手术部位放置一种新型的胶原青光眼引流装置,以维持术后引流。术后1年分析患者的数据,包括眼内压(IOP),并发症和维持足够压力所需的药物数量。结果:术后1至2个月内,有80.9%的患者眼压低于21毫米汞柱。术后3到6个月时提高到88.9%,术后6到12个月时提高到87.5%。唯一的主要并发症是与手术技术有关的微穿孔(8.6%)和少数需要重复手术的高眼压(10.3%)。结论:非穿透性的根管消融技术可有效地将房水引流至可接受的水平(15至17 mm Hg范围),而不会引起穿透性小梁切除术相关的并发症。并发症很少见,胶原蛋白引流装置似乎对于使引流部位在溶解后仍保持专利有效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号